Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Procter & Gamble Co, Teva Pharmaceuticals Industries Limited Joint Venture Approved By EU Watchdog-Reuters


Monday, 12 Nov 2012 05:45am EST 

Reuters reported that Procter & Gamble Co and Teva Pharmaceuticals Industries Limited gained EU regulatory approval on November 12, 2012 to set up a joint venture to sell over-the-counter medicines. The European Commission said the transaction would not raise competition concerns because it would not significantly alter the market in remedies for conditions such as pain and arthritis, particularly in the Baltics. 

Company Quote

84.18
0.91 +1.09%
4:00pm EDT